The first patient received dosing at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.

Please provide your email address to receive an email when new articles are posted on . One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results ...

The drug candidate at the center of AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics has failed a pair of phase 2 trials, dealing a blow to the program and a boost to rival Bristol Myers ...

GH Research announced positive Phase 2a trial results for GH001 in postpartum and bipolar II depression, with high remission rates. GH Research PLC announced significant progress in its clinical ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...